Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-05 Sale | 2024-07-08 5:59 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 1,337 | $2.5077 | $3,353 | 112,614 (Direct) | View |
| 2024-07-05 Sale | 2024-07-08 5:58 pm | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 2,475 | $2.5077 | $6,207 | 128,012 (Direct) | View |
| 2024-07-05 Sale | 2024-07-08 5:57 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 2,475 | $2.5077 | $6,207 | 159,312 (Direct) | View |
| 2024-07-05 Sale | 2024-07-08 5:55 pm | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 2,638 | $2.5077 | $6,615 | 242,045 (Direct) | View |
| 2024-07-05 Sale | 2024-07-08 5:54 pm | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 527 | $2.5077 | $1,322 | 187,718 (Direct) | View |
| 2024-07-05 Sale | 2024-07-08 5:53 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 7,662 | $2.5077 | $19,214 | 549,674 (Direct) | View |
| 2024-05-23 Sale | 2024-05-24 4:15 pm | G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer | 5,826 | $4.2678 | $24,864 | 109,825 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:12 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 8,151 | $4.7888 | $39,034 | 78,951 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:11 pm | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 8,151 | $4.7888 | $39,034 | 153,245 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:10 pm | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 8,151 | $4.7888 | $39,034 | 95,487 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:08 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 8,151 | $4.7888 | $39,034 | 161,787 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:07 pm | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 8,151 | $4.7888 | $39,034 | 209,683 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:06 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 37,258 | $4.7888 | $178,421 | 452,336 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Secor Alicia Director | 10,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Secor Alicia Director | 110,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer | 6,674 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer | 344,026 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director | 15,889 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director | 110,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 14,389 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 110,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Lee Jacks Director | 10,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Lee Jacks Director | 130,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 196,287 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 181,400 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 897,387 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 19,331 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 348,887 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 87,450 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 17,900 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 294,219 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 26,035 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 20,600 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 367,110 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Sharpless Norman Director | 80,000 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 21,150 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 17,900 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 234,962 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 14,232 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 16,100 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 213,632 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 185,358 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 160,000 | $0 | 0 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:34 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 35,000 | $0 | 113,951 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:32 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 35,000 | $0 | 130,487 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:27 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer | 35,000 | $0 | 144,825 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:26 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 35,000 | $0 | 244,683 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:24 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 35,000 | $0 | 188,245 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:22 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 105,000 | $0 | 557,336 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:43 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Sharpless Norman Director | 40,000 | $0 | 50,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:42 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Secor Alicia Director | 40,000 | $0 | 60,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:41 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 40,000 | $0 | 235,358 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:40 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Lee Jacks Director | 40,000 | $0 | 50,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:39 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director | 40,000 | $0 | 65,889 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:37 pm | N/A 2034-06-13 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 40,000 | $0 | 64,389 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 4:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel | 37,500 | $0 | 115,651 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 4:09 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 100,000 | $0 | 217,834 (Direct) | View |